1. Home
  2. CMC vs RYTM Comparison

CMC vs RYTM Comparison

Compare CMC & RYTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Commercial Metals Company

CMC

Commercial Metals Company

HOLD

Current Price

$64.24

Market Cap

7.5B

Sector

Industrials

ML Signal

HOLD

Logo Rhythm Pharmaceuticals Inc.

RYTM

Rhythm Pharmaceuticals Inc.

HOLD

Current Price

$90.66

Market Cap

6.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CMC
RYTM
Founded
1915
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Steel/Iron Ore
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.5B
6.3B
IPO Year
1994
2017

Fundamental Metrics

Financial Performance
Metric
CMC
RYTM
Price
$64.24
$90.66
Analyst Decision
Buy
Strong Buy
Analyst Count
12
19
Target Price
$79.27
★ $143.94
AVG Volume (30 Days)
★ 1.0M
659.4K
Earning Date
10-15-2026
11-03-2026
Dividend Yield
★ 1.24%
N/A
EPS Growth
★ 691.89
28.34
EPS
★ 5.86
N/A
Revenue
★ $7,918,430,000.00
N/A
Revenue This Year
$9.67
$66.07
Revenue Next Year
$0.49
$79.32
P/E Ratio
$11.05
★ N/A
Revenue Growth
★ 25.57
N/A
52 Week Low
$55.97
$74.50
52 Week High
$84.87
$122.20

Technical Indicators

Market Signals
Indicator
CMC
RYTM
Relative Strength Index (RSI) 48.46 34.73
Support Level $60.30 $87.19
Resistance Level $66.16 $91.70
Average True Range (ATR) 2.08 3.15
MACD 0.30 -0.05
Stochastic Oscillator 46.22 24.49

Price Performance

Historical Comparison
CMC
RYTM

About CMC Commercial Metals Company

Commercial Metals Co is a manufacturer and supplier of early-stage construction materials, including steel reinforcing bars, concrete pipes, precast products, and soil stabilization solutions. It also produces merchant bar, steel fence posts, and wire rod, serving domestic and some international markets in Europe and Asia. Its products are used in infrastructure and building projects such as highways, bridges, airports, and commercial and residential buildings.

About RYTM Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company engaged in the development and commercialization of therapies for patients with rare neuroendocrine diseases. The company is focused on advancing its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. In addition, it has two early-stage investigational MC4R agonists in clinical development, RM-718 and bivamelagon, designed not to cause hyperpigmentation. The company is also focused on advancing potential candidates for congenital hyperinsulinism. It currently operates in two business segments: the United States, which generates maximum revenue, and International.

Share on Social Networks: